Short-chain fatty acids (SCFAs): |
|
Blottière et al., 2003; Backhed et al., 2004; Xiong et al., 2004; Samuel et al., 2008; Tolhurst et al., 2012; De Vadder et al., 2014
|
E.g., Acetate, butyrate, propionate, hexanoate, valerate |
energy homeostasis; synthesis of glucagon-like peptide 1 (GLP-1); increase leptin production.
Improve glucose tolerance and insulin sensitivity.
Potent histone deacetylase (HDAC) inhibitor - regulation of intestinal cell proliferation.
Intestinal gluconeogenesis, lipogenesis, suppression of fasting-induced adipose factor Fiaf (lipoprotein lipase inhibitor) in intestinal epithelium.
Immunomodulatory effect, activate dendritic cells, gut immunity.
|
|
Indole derivatives: |
|
Bendheim et al., 2002; Deguchi et al., 2002; Wikoff et al., 2009; Venkatesh et al., 2014
|
E.g., Indole, indoxyl sulfate, indole-3-propionic acid (IPA) |
IPA regulates intestinal barrier function via the xenobiotic sensor, pregnane X receptor (PXR), in which it reduces intestinal inflammation (downregulates enterocyte pro-inflammatory cytokines TNF-α), and regulate intestinal permeability and mucosal integrity (upregulates junctional protein-coding mRNAs).
Indoxyl sulfate as uremic toxin that accumulates in the blood of patients with impaired excretion system.
|
|
Bile acid metabolites: E.g., Deoxycholic acid (DCA), lithocholic acid (LCA) |
Activate host nuclear receptors and cell signaling pathways: regulation of bile acid, cholesterol, glucose, lipid, and energy metabolism.
Exhibit antimicrobial effects.
|
Inagaki et al., 2006; Hylemon et al., 2009
|
Choline metabolites: |
|
Dumas et al., 2006; Wang Z. et al., 2011
|
E.g., Choline, trimethylamine N-oxide (TMAO) and betaine |
|
|
Phenolic derivatives: |
|
Larrosa et al., 2006, 2010; Lee H.C. et al., 2006; Selma et al., 2009
|
E.g., 4-OH phenylacetic acid, equol, urolithins, enterolactone, enterodiol, 8-prenylnaringenin, 2-(3,4-dihydroxyphenyl)acetic acid, 3-(4-hydroxyphenyl)propionic acid, 5-(3,4-dihydroxyphenyl)valeric acid |
Protective effect against oxidative stress.
Estrogen-modulating effect.
Platelet aggregation inhibition effect.
Urolithin exhibits anti-inflammatory and cancer chemopreventive effects.
|
|
Vitamins: |
|
LeBlanc et al., 2011; Nicholson et al., 2012; Forster et al., 2017; Lerner et al., 2017b
|
E.g., Thiamine (B1), riboflavin (B2), niacin (B3), pyridoxine (B6), pantothenic acid (B5), biotin (B7), folate (B11–B9), cobalamin (B12), and menaquinone (K2) |
DNA replication, repair and methylation, regulating cell proliferation.
Production of nucleotides, vitamins and amino acids.
Enhance immune functioning.
|
|
Polyamines: |
|
Guo et al., 2003, 2005; Perez-Cano et al., 2010; Johnson et al., 2015; Rooks and Garrett, 2016
|
E.g., putrescine, spermidine, and spermine |
Dysregulated polyamine metabolism possibly enhances cancer development.
Enhance intestinal barrier integrity and function via stimulating synthesis of intercellular junction proteins
[occludin, zonula occludens-1 (ZO-1), E-cadherin].
Enhance maturation of intestinal and systemic adaptive immune system.
Spermine inhibits pro-inflammatory M1 macrophage activation.
|
|